SG11202007887VA - Cyclic peptides and uses thereof - Google Patents

Cyclic peptides and uses thereof

Info

Publication number
SG11202007887VA
SG11202007887VA SG11202007887VA SG11202007887VA SG11202007887VA SG 11202007887V A SG11202007887V A SG 11202007887VA SG 11202007887V A SG11202007887V A SG 11202007887VA SG 11202007887V A SG11202007887V A SG 11202007887VA SG 11202007887V A SG11202007887V A SG 11202007887VA
Authority
SG
Singapore
Prior art keywords
cyclic peptides
peptides
cyclic
Prior art date
Application number
SG11202007887VA
Inventor
Andrew Gearing
Original Assignee
Lateral IP Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2018901063A external-priority patent/AU2018901063A0/en
Application filed by Lateral IP Pty Ltd filed Critical Lateral IP Pty Ltd
Publication of SG11202007887VA publication Critical patent/SG11202007887VA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Immunology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
SG11202007887VA 2018-03-29 2019-03-29 Cyclic peptides and uses thereof SG11202007887VA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2018901063A AU2018901063A0 (en) 2018-03-29 Cyclic peptides and uses thereof
PCT/AU2019/050285 WO2019183686A1 (en) 2018-03-29 2019-03-29 Cyclic peptides and uses thereof

Publications (1)

Publication Number Publication Date
SG11202007887VA true SG11202007887VA (en) 2020-09-29

Family

ID=68062416

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202007887VA SG11202007887VA (en) 2018-03-29 2019-03-29 Cyclic peptides and uses thereof

Country Status (10)

Country Link
US (1) US11566049B2 (en)
EP (1) EP3774848B1 (en)
JP (1) JP7374117B2 (en)
KR (1) KR20200138743A (en)
CN (1) CN111936508A (en)
AU (1) AU2019240773B2 (en)
CA (1) CA3093594A1 (en)
RU (1) RU2020131598A (en)
SG (1) SG11202007887VA (en)
WO (1) WO2019183686A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20230064978A1 (en) * 2019-12-27 2023-03-02 Lateral IP Pty Ltd Cyclic peptide receptor lanthionine synthetase c-like protein (lancl) and uses thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6271196B1 (en) 1996-03-05 2001-08-07 Regents Of The University Of Ca Methods of alleviating neuropathic pain using prosaposin-derived peptides
US6262228B1 (en) * 1998-08-17 2001-07-17 Tularik Inc. IRAK3 polypeptides and methods
AUPP589598A0 (en) 1998-09-14 1998-10-08 University Of Queensland, The Novel peptides
AU2008334095A1 (en) * 2007-11-29 2009-06-11 Genentech, Inc. Gene expression markers for inflammatory bowel disease
JP5447784B2 (en) 2009-03-12 2014-03-19 国立大学法人 鹿児島大学 A therapeutic agent for neuropathic pain containing a partial peptide of maxadilan
CA2921324C (en) 2013-09-18 2022-11-22 Bcn Peptides S.A. Cortistatin analogues for the treatment of inflammatory and/or immune diseases
EP3976086A1 (en) * 2019-05-31 2022-04-06 Lateral Ip Pty Ltd Peptides and uses thereof
WO2022232885A1 (en) * 2021-05-07 2022-11-10 Lateral Pharma Pty Ltd Compositions for treating inflammatory airway disease and uses thereof

Also Published As

Publication number Publication date
RU2020131598A (en) 2022-04-29
JP7374117B2 (en) 2023-11-06
WO2019183686A1 (en) 2019-10-03
KR20200138743A (en) 2020-12-10
EP3774848B1 (en) 2023-02-22
EP3774848A4 (en) 2021-12-15
EP3774848A1 (en) 2021-02-17
AU2019240773A1 (en) 2020-09-10
AU2019240773B2 (en) 2024-05-16
CA3093594A1 (en) 2019-10-03
US20210130410A1 (en) 2021-05-06
US11566049B2 (en) 2023-01-31
JP2021519327A (en) 2021-08-10
CN111936508A (en) 2020-11-13

Similar Documents

Publication Publication Date Title
IL275298B1 (en) Mitochondria-targeting peptides
IL268593A (en) Polypeptide variants and uses thereof
IL290414A (en) Atf5 peptide variants and uses thereof
IL265834A (en) Hla-restricted vgll1 peptides and use thereof
SG11202006669RA (en) Peptides and uses thereof
IL280808A (en) Ox40-binding polypeptides and uses thereof
GB201817821D0 (en) TCR and peptides
GB201819200D0 (en) Polypeptide and uses thereof
EP3706771A4 (en) Bcl9 peptides and variants thereof
EP3649146C0 (en) Apelin peptides and uses thereof
EP3480212C0 (en) Il13ralpha2 peptide and its uses
EP3947418C0 (en) Peptides and use thereof
ZA201904386B (en) S-arrestin peptides and therapeutic uses thereof
SG11202007887VA (en) Cyclic peptides and uses thereof
IL280450A (en) Cdca1-derived peptide and vaccine containing same
EP3615551A4 (en) Modified cyclic peptides and therapeutic use thereof
EP3475293A4 (en) Novel cyclic peptides and uses thereof
HUP1700012A2 (en) Novel proteins and use thereof
AU2018901063A0 (en) Cyclic peptides and uses thereof
IL284666A (en) Novel peptides and uses thereof
AU2019903600A0 (en) Cyclic peptides and uses thereof
GB201818663D0 (en) Peptides and method
GB201817486D0 (en) Peptides and conjugates
GB201812328D0 (en) Polypeptides and uses thereof
GB201803401D0 (en) Polypeptide and vaccine